Cytochroma
Company

Last deal

$43.96M
Local Amount - CAD 45M

Amount

Series C

Stage

30.07.2008

Date

3

all rounds

$75.83M

Total amount

date founded

Financing round

General

About Company
Cytochroma develops prescription products for vitamin D insufficiency and hyperparathyroidism in kidney disease.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1996

Operating Status

Closed (01.01.2013)

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

The company has an advanced portfolio of therapies to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. Additionally, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels in order to improve the control of SHPT in CKD patients.
Contacts
Similar Companies
1000
CorMedix

CorMedix

CorMedix is a specialty pharmaceutical company that develops products for the treatment of cardiac, renal, and infectious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Bridgewater Township, NJ, USA

total rounds

4

total raised

$11.47M
ARS Pharmaceuticals

ARS Pharmaceuticals

ARS Pharmaceuticals developed a novel intranasal epinephrine spray with a unique absorption technology to treat severe allergic reactions.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Health Care, Biotechnology, Pharmaceuticals

Location

San Diego, CA, USA

total rounds

2

total raised

$75M
Xeris Pharmaceuticals

Xeris Pharmaceuticals

Xeris is a pharmaceutical company that develops and commercializes ready-to-use, liquid-stable injectables.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Location

Chicago, IL, USA

total rounds

14

total raised

$548.5M
Cosmo Pharmaceuticals

Cosmo Pharmaceuticals

Cosmo Pharmaceuticals develops innovative treatments for gastro-intestinal diseases and colon infections.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Health Care, Pharmaceuticals, Biotechnology

Location

Dublin, Ireland

total rounds

1

total raised

$25M
M&A Details
1

Transaction name

Acquired by

OPKO Health

announced date

08.01.2013

Financials

Funding Rounds
6
3

Number of Funding Rounds

$75.83M

Money Raised

Their latest funding was raised on 30.07.2008. Their latest investor T2C2 Capital. Their latest round Series C

Date 
Funding Round 
Investors 
Money Raised 
Lead 
30.07.2008
8
$43.96M
Local Amount - CAD 45M
18.01.2007
2
$17.87M
Local Amount - CAD 21M
04.12.2002
$4.17M
BDC Capital Corporation

BDC Capital Corporation

BDC Capital provides innovative financing solutions to New England businesses that may face challenges obtaining traditional loans.

Sector

Finance and Credit Services

Subsector

Consumer Lending

Keywords

Financial Services, Finance, Venture Capital

Location

Wakefield, MA 01880, USA

count Of Investments

55

count Of Exists

22
Novo Holdings

Novo Holdings

Novo Holdings is a life science investor focused on growing investment assets for scientific, social, and humanitarian purposes.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

2900 Hellerup, Denmark

count Of Investments

303

count Of Exists

43
VentureLink LP

VentureLink LP

VentureLink LP is a labor-sponsored fund specializing in debt-related securities and equity holdings.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Toronto, ON, Canada

count Of Investments

20

count Of Exists

6
Mitsubishi Tanabe Pharma

Mitsubishi Tanabe Pharma

Mitsubishi Tanabe Pharma creates pharmaceuticals to contribute to the healthier lives of people worldwide.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Pharmaceuticals, Health Care, Financial Services

Location

Osaka, Japan

count Of Investments

1

count Of Exists

1
Caisse de Depot et Placement du Quebec

Caisse de Depot et Placement du Quebec

CDPQ is a global investment group that generates sustainable returns.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Finance, Banking

Location

Dorval, QC, Canada

count Of Investments

193

count Of Exists

34
Co-Investors
Investors
11
6

Number of lead investors

11

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series B
Yes
Series C
T2C2 Capital

T2C2 Capital

T2C2 identifies and commercializes business opportunities in universities, research centers, and industry.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Financial Services, Venture Capital, Finance

Location

Dorval, QC, Canada

count Of Investments

11

count Of Exists

6
BDC Capital Corporation

BDC Capital Corporation

BDC Capital provides innovative financing solutions to New England businesses that may face challenges obtaining traditional loans.

Sector

Finance and Credit Services

Subsector

Consumer Lending

Keywords

Financial Services, Finance, Venture Capital

Location

Wakefield, MA 01880, USA

count Of Investments

55

count Of Exists

22
Novo Holdings

Novo Holdings

Novo Holdings is a life science investor focused on growing investment assets for scientific, social, and humanitarian purposes.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

2900 Hellerup, Denmark

count Of Investments

303

count Of Exists

43
Acquisitions
1
Acquiree Name 
Date 
Price 
Acquisition Name 
Proventiv Therapeutics acquired by Cytochroma

Proventiv Therapeutics acquired by Cytochroma

acquirer

Cytochroma
Cytochroma

date

29.06.2006

type

Acquisition
Proventiv Therapeutics

Proventiv Therapeutics

Proventiv Therapeutics develops and sells pharmaceutical products to treat and prevent the clinical consequences of vitamin D deficiency.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Fitchburg, WI, USA

People

Employee Profiles
1
Charles Bishop

Charles Bishop

CEO

Activity

Recent News
0